Oriola Oyj (LON: 0NES)
London
· Delayed Price · Currency is GBP · Price in EUR
0.940
+0.004 (0.43%)
Jan 23, 2025, 12:19 PM BST
Oriola Oyj Revenue
Oriola Oyj had revenue of 424.40M EUR in the quarter ending September 30, 2024, with 18.58% growth. This brings the company's revenue in the last twelve months to 1.63B, up 8.04% year-over-year. In the year 2023, Oriola Oyj had annual revenue of 1.50B, down -2.90%.
Revenue (ttm)
1.63B EUR
Revenue Growth
+8.04%
P/S Ratio
n/a
Revenue / Employee
1.82M EUR
Employees
895
Market Cap
145.39M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.50B | -44.60M | -2.90% |
Dec 31, 2022 | 1.54B | 87.50M | 6.03% |
Dec 31, 2021 | 1.45B | -348.70M | -19.36% |
Dec 31, 2020 | 1.80B | 79.30M | 4.61% |
Dec 31, 2019 | 1.72B | 169.40M | 10.91% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |